"Magic bullets"--monoclonal antibodies in acute leukemia and non-Hodgkin's lymphoma treatment
Łuczyński, W.ło.; Krawczuk-Rybak, M.
Postepy Higieny i Medycyny Doswiadczalnej 56(6): 789-801
2002
ISSN/ISBN: 0032-5449 PMID: 12669700 Document Number: 548382
Because of high percent of failures in haematologic malignancies treatment there is a need of discovering new drugs. One of the new approaches are monoclonal antibodies, which target specific cluster differentiation antigens on tumor cells. Rituximab is an anti-CD20 antibody used in non-Hodgkin lymphoma, alemtuzumab--in B chronic lymphocytic leukaemia, gemtuzumab ozogamicin--in non-lymphoblastic leukaemia, tositumomab and ibritumomab are monoclonal antibodies binded with radiopharmaceutics and are used in non-Hodgkin lymphomas.
Document emailed within 1 workday
Related Documents
Malberg, K.; Fischer, H.; Elendt, D.; Wutke, K.; Fiebig, H. 1984: Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2 Archiv für Geschwulstforschung 54(4): 325-332LeBien, T.W.; McKenna, R.W.; Abramson, C.S.; Gajl-Peczalska, K.J.; Nesbit, M.E.; Coccia, P.F.; Bloomfield, C.D.; Brunning, R.D.; Kersey, J.H. 1981: Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma Cancer Research 41(11 Part 2): 4776-4780
Sciarra, A.; Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Olivieri, M.; Perrotti, A.; Zaccari, G.; Amadori, S.; Papa, G. 1995: Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Recenti Progressi in Medicina 86(2): 57-62
Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Sciarra, A.; Perrotti, A.; Zaccari, G.; Papa, G. 1993: Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Thrombosis and Haemostasis 70(4): 568-572
Shimoyama, M. 1985: Monoclonal antibodies and immunodiagnosis of leukemia/lymphoma Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(8): 1711-1730
Hung, I.J.; Yang, C.P. 1989: Evaluation of methotrexate containing chemotherapeutic regimens in the treatment of childhood undifferentiated non-Hodgkin's lymphoma and B cell acute lymphoblastic leukemia Journal of the Formosan Medical Association 88(10): 1016-1022
Mitarnun, W.; Pradutkanchana, J.; Takao, S.; Saechan, V.; Suwiwat, S.; Ishida, T. 2002: Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis Journal of the Medical Association of Thailand 85(5): 552-559
Srivastava, B.I.; Wong-Staal, F.; Getchell, J.P. 1986: Human T-cell leukemia virus i provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma Cancer Research 46(9): 4756-4758
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Van Melick, E.J.; Haak, H.L.; te Velde, J. 1988: A patient with acute non-lymphatic leukemia 2 years after non-Hodgkin lymphoma Nederlands Tijdschrift Voor Geneeskunde 132(15): 684-687
Weil, M. 1981: Therapeutic methods for meningitis in acute lymphoblastic leukemia and Hodgkin's lymphoma Nouvelle Revue Francaise d'Hematologie 23(5): 303-304
Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120
Svejgaard, A.; Madsen, H.O.; Nyvold, C.; Ryder, L.P.; Schmiegelow, K. 1996: Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma Ugeskrift for Laeger 158(49): 7101-7102
Lederlin, P.; Witz, F.; Aymard, J.P.; Colomb, J.N. 1979: Acute myeloblastic leukemia, a late complication of non-Hodgkin's malignant lymphoma. 2 cases La Nouvelle Presse Medicale 8(38): 3060
Vaisitti, T.; Deaglio, S.; Malavasi, F. 2005: Cationization of monoclonal antibodies: another step towards the "magic bullet"? Journal of Biological Regulators and Homeostatic Agents 19(3-4): 105-112
Carter, K. 1987: Hospitals test monoclonal antibodies' "magic bullet" potential Modern Healthcare 17(11): 56
Huber, H.; Gattringer, C.; Thaler, J.; Peschel, C. 1985: Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms Behring Institute Mitteilungen 78: 83-117
Matsuo, Y.; Hagiwara, S.; Okubo, K.; Matsumoto, K.; Sagawa, K.; Yokoyama, M.M. 1985: Monoclonal antibodies (NU-N1 and NU-N2) reactive with common acute lymphoblastic leukemia antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(3): 775-783
Jones-Bey, H. 1992: Magic bullets pursue recurrent breast cancer Diagnostic Imaging 14(9): 97; 103-113
Sharkunov, N.N.; Moiseyeva, T.N.; Zybunova, E.E.; Vinogradova, O.Y.; Kravchenko, S.K. 2012: Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia Terapevticheskii Arkhiv 84(11): 71-74